Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 10858256)

1.
2.

Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.

Nikolic B, Lee S, Bronson RT, Grusby MJ, Sykes M.

J Clin Invest. 2000 May;105(9):1289-98.

3.

Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease.

Carayol G, Bourhis JH, Guillard M, Bosq J, Pailler C, Castagna L, Vernant JP, Pico JL, Hayat M, Chouaib S, Caignard A.

Transplantation. 1997 May 15;63(9):1307-13.

PMID:
9158026
4.

Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603.

Lu Y, Sakamaki S, Kuroda H, Kusakabe T, Konuma Y, Akiyama T, Fujimi A, Takemoto N, Nishiie K, Matsunaga T, Hirayama Y, Kato J, Kon S, Kogawa K, Niitsu Y.

Blood. 2001 Feb 15;97(4):1123-30.

5.

Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.

Murphy WJ, Welniak LA, Taub DD, Wiltrout RH, Taylor PA, Vallera DA, Kopf M, Young H, Longo DL, Blazar BR.

J Clin Invest. 1998 Nov 1;102(9):1742-8.

6.

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.

Blazar BR, Sharpe AH, Chen AI, Panoskaltsis-Mortari A, Lees C, Akiba H, Yagita H, Killeen N, Taylor PA.

Blood. 2003 May 1;101(9):3741-8. Epub 2003 Jan 9.

8.

Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.

Zeis M, Uharek L, Hartung G, Glass B, Steinmann J, Schmitz N.

Hematol J. 2001;2(2):136-44.

PMID:
11424006
9.

Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway.

Mariotti J, Foley J, Ryan K, Buxhoeveden N, Kapoor V, Amarnath S, Fowler DH.

Blood. 2008 Dec 1;112(12):4765-75. doi: 10.1182/blood-2008-05-154278. Epub 2008 Jul 14.

10.

[Effects of HGF on GVHD and Th1/Th2-related cytokines in ALL mice after allo-BMT].

Xia YJ, Gao QP, Wan CC, Cheng FJ, Wang WM, Guo RC.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Feb;13(1):35-8. Chinese.

PMID:
15748432
11.

Graft-versus-host disease and the Th1/Th2 paradigm.

Krenger W, Ferrara JL.

Immunol Res. 1996;15(1):50-73. Review.

PMID:
8739565
12.

Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease.

Aharoni R, Schlegel PG, Teitelbaum D, Roikhel-Karpov O, Chen Y, Arnon R, Sela M, Chao NJ.

Immunol Lett. 1997 Jul;58(2):79-87.

PMID:
9271317
13.

Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.

Maeda Y, Reddy P, Lowler KP, Liu C, Bishop DK, Ferrara JL.

Blood. 2005 Jul 15;106(2):749-55. Epub 2005 Mar 29.

16.

The flavonoid Kaempferol suppresses the graft-versus-host reaction by inhibiting type 1 cytokine production and CD8+ T cell engraftment.

Okamoto I, Iwaki K, Koya-Miyata S, Tanimoto T, Kohno K, Ikeda M, Kurimoto M.

Clin Immunol. 2002 May;103(2):132-44.

PMID:
12027418
17.

Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.

Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I, LeBon T, Kandeel F, Forman S, Zeng D.

Blood. 2008 Sep 1;112(5):2101-10. doi: 10.1182/blood-2007-12-126987. Epub 2008 Jul 2.

18.

Co-stimulated/Tc2 cells abrogate murine marrow graft rejection.

Erdmann AA, Jung U, Foley JE, Toda Y, Fowler DH.

Biol Blood Marrow Transplant. 2004 Sep;10(9):604-13.

20.

[Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].

Cao J, Li L, Chen C, Zeng LY, Li ZY, Pan XY, Xu KL.

Zhonghua Xue Ye Xue Za Zhi. 2011 Feb;32(2):83-8. Chinese.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk